Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion type Assertion NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_head.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion description "[Assessment of MYC mRNA levels is feasible and may be incorporated in prospective PNET/MB clinical trials to aid in treatment planning for patients with PNET/MB on confirmation of our results in larger studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_provenance.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion evidence source_evidence_literature NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_provenance.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion SIO_000772 11489822 NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_provenance.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion wasDerivedFrom befree-20150227 NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_provenance.
- NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_assertion wasGeneratedBy ECO_0000203 NP582004.RAeLYVmO7QPXXtGQBSgq4BsPhSIu3S4Ge60Qb-qVddZV0130_provenance.